For a condition as prevalent and dangerous as obesity (see page S50), we know surprisingly little about its causes and cures. We have much to learn about how fat tissue stores and burns lipids; there may even be new types of human fat cell yet to be discovered (S52). And although it is clear that the types of microbe living in the gut correlate with body weight, we do not know whether changes in these populations are a cause of weight gain, or a consequence (S61).
The best way to lose weight is to eat less and exercise more. But as a strategy to combat obesity at the population level, this common-sense prescription is proving ineffective over the long term. Tailored treatment programmes that factor in the stresses and temptations of the real world, using insights from behavioural research, are showing some success. Drugs may also form part of the solution (S54). Or perhaps the pharmaceutical option should be a last resort, and society should instead use the power of government regulation to encourage healthier lifestyle options (S57).
Of course, obesity does not result from the environment alone — it is one of our most strongly genetically influenced traits. Scores of genes have been implicated, but the evidence suggests that something other than genes accounts for whether someone is likely to become obese (S58).
Controlling appetite is not just a matter of will power; much of our dietary behaviour is hardwired. Neuroscientists are using new techniques to map the neural circuits that control when and how much we eat (S64). But these appetite systems, which evolved to ensure we have enough of the right nutrients, are now being subverted by modern food processing (S66).
We are pleased to acknowledge the financial support of Nestlé Research Center in producing this Outlook. As always, Nature retains sole responsibility for all editorial content.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Scully, T. Obesity. Nature 508, S49 (2014). https://doi.org/10.1038/508S49a
Published:
Issue Date:
DOI: https://doi.org/10.1038/508S49a
This article is cited by
-
HMGB2 orchestrates mitotic clonal expansion by binding to the promoter of C/EBPβ to facilitate adipogenesis
Cell Death & Disease (2021)
-
Stages of Change Readiness and Treatment Eagerness Scale in Overweight and Obesity’s Psychometric Properties (SOCRATES-OO)
Journal of Clinical Psychology in Medical Settings (2020)
-
Human hepatic 3D spheroids as a model for steatosis and insulin resistance
Scientific Reports (2018)
-
Hepatocyte nuclear factor 1b is a novel negative regulator of white adipocyte differentiation
Cell Death & Differentiation (2017)
-
Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction
Nature Communications (2015)